Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
JPT Stock Summary
Top 10 Correlated ETFs
JPT
In the News

The Quality Closed-End Fund Report, April 2023
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given.

Preferred Closed-End Funds: Out Of The Frying Pan Into The Fire
Today, I wanted to take a broader look at the preferred closed-end fund space. After struggling for most of the last year due to rapidly-rising interest rates, the latest banking failures sent preferred CEFs spiraling.

The 'High-High-Low' Closed-End Fund Report, December 2022
Only funds with yields over 8%, coverage higher than 90% and trading at a discount are considered. Top lists of discount, yield, DxY and DxYxZ are given.

Quality Closed-End Fund Report, November 2022
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY, and DxYxZ are given.

Weekly Closed-End Fund Roundup: SPE Tender, GUT Rights, JPT/FTF Results (March 6, 2022)
Weekly Closed-End Fund Roundup: SPE Tender, GUT Rights, JPT/FTF Results (March 6, 2022)

CEF Weekly Market Review: When It Rains It Pours
CEF Weekly Market Review: When It Rains It Pours

Recent Moves In CEFs And Our Views
The stock market has seen a noticeable reversal over the last few days. The moves in the CEF market have been fairly benign so far, a result of a number of factors which have lowered its beta relative to stocks.

Tower Research Capital LLC TRC Has $58,000 Stake in Macerich Co (NYSE:MAC)
Tower Research Capital LLC TRC lifted its holdings in Macerich Co (NYSE:MAC) by 151.8% during the first quarter, Holdings Channel.com reports. The institutional investor owned 10,282 shares of the real estate investment trust’s stock after acquiring an additional 6,199 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Macerich were worth $58,000 as […]

Invesco Ltd. Grows Holdings in Cohen & Steers, Inc. (NYSE:CNS)
Invesco Ltd. increased its position in shares of Cohen & Steers, Inc. (NYSE:CNS) by 15.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 333,073 shares of the asset manager’s stock after purchasing an additional 45,042 shares during the quarter. Invesco Ltd. owned […]

Jane Street Group LLC Takes $375,000 Position in Establishment Labs Holdings Inc (NASDAQ:ESTA)
Jane Street Group LLC bought a new stake in Establishment Labs Holdings Inc (NASDAQ:ESTA) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 25,977 shares of the company’s stock, valued at approximately $375,000. Several other hedge funds and other institutional investors have also […]
JPT Financial details
JPT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-07-31
Metric | History | 2018-07-31 | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2022-07-31 |
---|---|---|---|---|---|---|
Revenue per share | -0.19 | 1.79 | 0.04 | 3.64 | 0 | |
Net income per share | -0.22 | 1.77 | 0.02 | 3.62 | 0 | |
Operating cash flow per share | 1.57 | 1.32 | 2.12 | -0.02 | 0 | |
Free cash flow per share | 1.57 | 1.32 | 2.12 | -0.02 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 25.17 | 24.29 | 21.27 | 25.03 | 0 | |
Tangible book value per share | 25.17 | 24.29 | 21.27 | 25.03 | 0 | |
Share holders equity per share | 25.17 | 24.29 | 21.27 | 25.03 | 0 | |
Interest debt per share | 6.71 | 6.52 | 5.2 | 6.92 | 0 | |
Market cap | 150.29M | 162.97M | 170.34M | 174.27M | 0 | |
Enterprise value | 192.79M | 206.14M | 207.64M | 221.31M | 47M | |
P/E ratio | -105.32 | 13.5 | 1.16K | 7.03 | 0 | |
Price to sales ratio | -119.48 | 13.35 | 570.73 | 6.99 | 0 | |
POCF ratio | 14.77 | 18.08 | 10.97 | -1.15K | 0 | |
PFCF ratio | 14.77 | 18.08 | 10.97 | -1.15K | 0 | |
P/B Ratio | 0.92 | 0.98 | 1.09 | 1.02 | 0 | |
PTB ratio | 0.92 | 0.98 | 1.09 | 1.02 | 0 | |
EV to sales | -153.27 | 16.88 | 695.71 | 8.88 | -3.57 | |
Enterprise value over EBITDA | -461.54 | 15.39 | 203.8 | 8.8 | -3.74 | |
EV to operating cash flow | 18.95 | 22.87 | 13.37 | -1.47K | 0.72 | |
EV to free cash flow | 18.95 | 22.87 | 13.37 | -1.47K | 0.72 | |
Earnings yield | -0.01 | 0.07 | 0 | 0.14 | 0 | |
Free cash flow yield | 0.07 | 0.06 | 0.09 | 0 | 0 | |
Debt to equity | 0.28 | 0.27 | 0.25 | 0.29 | 0.52 | |
Debt to assets | 0.22 | 0.21 | 0.2 | 0.22 | 0.34 | |
Net debt to EBITDA | -101.75 | 3.22 | 36.61 | 1.87 | -3.74 | |
Current ratio | 0.68 | 3.3 | 1.26 | 1.14 | 2.3 | |
Interest coverage | -0.41 | 10.14 | 1.17 | 68.45 | 0.07 | |
Income quality | -7.13 | 0.75 | 105.76 | -0.01 | -5 | |
Dividend Yield | 0.07 | 0.06 | 0.06 | 0.06 | 0 | |
Payout ratio | -7.13 | 0.8 | 65.13 | 0.39 | -0.33 | |
Sales general and administrative to revenue | -0.13 | 0.01 | 0.51 | 0.01 | -0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 11.16 | 31.1 | 3.09 | 45.15 | 0 | |
ROIC | 0 | 0.06 | 0.01 | 0.12 | 0 | |
Return on tangible assets | -0.01 | 0.06 | 0 | 0.11 | -0.18 | |
Graham Net | -6.82 | -6.17 | -5.12 | -6.95 | 0 | |
Working capital | -956.51K | 2.02M | 398.73K | 255.27K | 1.09M | |
Tangible asset value | 163.24M | 165.62M | 156.2M | 171.38M | 92.91M | |
Net current asset value | -43.69M | -41.35M | -37.1M | -47.05M | -46.05M | |
Invested capital | 0.26 | 0.26 | 0.24 | 0.27 | 0.51 | |
Average receivables | 2.07M | 2.48M | 2.43M | 2.03M | 2.02M | |
Average payables | 1.94M | 1.95M | 1.22M | 1.7M | 1.35M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | -597.78 | 86.86 | 2.39K | 30.9 | -53.74 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | -0.61 | 4.2 | 0.15 | 11.81 | -6.79 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.01 | 0.07 | 0 | 0.14 | -0.28 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-01-31 for Q4
Metric | History | 2020-01-31 | 2020-07-31 | 2022-01-31 | 2022-07-31 | 2023-01-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 39.23M | 37.3M | 47M | 47M | 44.13M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.24 | 0.25 | 0.29 | 0.52 | 0.5 | |
Debt to assets | 0.2 | 0.2 | 0.23 | 0.34 | 0.33 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.62 | 1.26 | 2.65 | 2.3 | 1.66 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 783.01K | 398.73K | 1.37M | 1.09M | 827.8K | |
Tangible asset value | 166.83M | 156.2M | 164.03M | 92.91M | 91.65M | |
Net current asset value | -38.74M | -37.1M | -45.87M | -46.05M | -43.69M | |
Invested capital | 0.24 | 0.24 | 0.29 | 0.51 | 0.48 | |
Average receivables | 2.48M | 2M | 0 | 2.07M | 1.88M | |
Average payables | 1.07M | 1.41M | 0 | 837.01K | 1.05M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
JPT Frequently Asked Questions
What is Nuveen Preferred and Income 2022 Term Fund stock symbol ?
Nuveen Preferred and Income 2022 Term Fund is a US stock , located in Chicago of Il and trading under the symbol JPT
What is Nuveen Preferred and Income 2022 Term Fund stock quote today ?
Nuveen Preferred and Income 2022 Term Fund stock price is $15.6 today.
Is Nuveen Preferred and Income 2022 Term Fund stock public?
Yes, Nuveen Preferred and Income 2022 Term Fund is a publicly traded company.